(Q52525188)
Statements
A new approach allowing an early prognosis in breast cancer: the ratio of estrogen receptor (ER) ligand binding activity to the ER-specific mRNA level. (English)
May E
Mouriesse H
May-Levin F
Contesso G
Delarue JC
1 August 1989
4
8
1037-1042